| Symbol | PARD |
|---|---|
| Name | PONIARD PHARMACEUTICALS, INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 98119 United States WA 300 Elliott Avenue West Suite 530 |
| Telephone | 206-281-7001 |
| Fax | — |
| — | |
| Website | http://www.poniard.com |
| Incorporation | US |
| Incorporated On | 1984 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Ernst & Young LLP; |
| Audit Status | NOT AVAILABLE |
| Reporting Status | Dark: Alternative Reporting Standard |
| CIK | 0000755806 |
| Description | Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products. For additional information please visit http://www.poniard.com. Additional info from OTC: |
No news found.